This article presents ongoing research at VIDO-InterVac for the development of safer and more effective adjuvants. These include adjuvants that stimulate innate immunity in the body and combination adjuvants.
Paul Hodgson
Advertisement
Paul Hodgson is an associate director business development at VIDO-InterVac
Articles by Paul Hodgson
Advertisement
Latest Updated Articles
Advertisement
Advertisement